Bi-directional metabolic reprogramming between cancer cells and T cells reshapes the anti-tumor immune response
PLOS Biology · 14.07.2025 · 23 (7) · e3003284
DOI: 10.1371/journal.pbio.3003284 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Biology, online erschienen am 14.07.2025. Verfasst von Yajing Qiu und 5 weiteren Autor:innen. Beteiligte Einrichtung: National Key Laboratory of Immunity and Inflammation, Suzhou Institute of Systems Medicine, Chinese Academy of Medical Sciences & Peking Union Medica…. Hauptthemen laut MEDLINE: Neoplasms, T-Lymphocytes. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 196 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Noncommunicable Chronic Diseases-National Science and Technology Major Project, National Natural Science Foundation of China, Central Research Institute Fund of the Chinese Academy of Medical Sciences.
Abstract (Originalsprache)
Cancer cells and T cells engage in dynamic crosstalk within the tumor microenvironment (TME), shaping tumor progression and anti-tumor immunity. While cancer cells reprogram metabolism to support growth and immune evasion, T cells must adapt their metabolic states to maintain effector functions. Tumor-driven metabolic perturbations, such as nutrient depletion and accumulation of immunosuppressive metabolites, profoundly impair T cell function and fate. Conversely, metabolically reprogrammed T cells can modulate the TME and influence tumor growth. This reciprocal metabolic crosstalk represents both metabolic competition and intercellular communication, offering promising therapeutic targets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- National Key Laboratory of Immunity and Inflammation, Suzhou Institute of Systems Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Suzhou, Jiangsu, China.
- Key Laboratory of Synthetic Biology Regulatory Elements, Suzhou Institute of Systems Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Suzhou, Jiangsu, China.
- Department of Pharmacy, Medical Science University and Suzhou Technology China Innovation Center, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School of Nanjing Medical U…
ORCID-Profile: Guideng Li
Förderung
- Noncommunicable Chronic Diseases-National Science and Technology Major Project
- National Natural Science Foundation of China
- Central Research Institute Fund of the Chinese Academy of Medical Sciences
- Innovation Fund for Medical Sciences (CIFMS)
- Gusu Innovation and Entrepreneurship Talent Program
- Basic Research Program of Jiangsu
- Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences
- CAMS Innovation Fund for Medical Sciences
Zitieren
APA
Qiu, Y., Xu, Y., Ding, X., Zhao, C., Cheng, H., & Li, G. (2025). Bi-directional metabolic reprogramming between cancer cells and T cells reshapes the anti-tumor immune response. PLOS Biology, 23(7), e3003284. https://doi.org/10.1371/journal.pbio.3003284
Vancouver
Qiu Y, Xu Y, Ding X, Zhao C, Cheng H, Li G. Bi-directional metabolic reprogramming between cancer cells and T cells reshapes the anti-tumor immune response. PLOS Biology. 2025;23(7):e3003284. doi:10.1371/journal.pbio.3003284
BibTeX
@article{Qiu2025,
author = {Qiu, Yajing and Xu, Yihan and Ding, Xinyuan and Zhao, Congcong and Cheng, Hongcheng and Li, Guideng},
title = {Bi-directional metabolic reprogramming between cancer cells and T cells reshapes the anti-tumor immune response},
journal = {PLOS Biology},
year = {2025},
volume = {23},
number = {7},
pages = {e3003284},
doi = {10.1371/journal.pbio.3003284}
}
EUVIMED